A Ferritin Nanoparticle-Based Zika Virus Vaccine Candidate Induces Robust Humoral and Cellular Immune Responses and Protects Mice from Lethal Virus Challenge

The severe consequences of the Zika virus (ZIKV) infections resulting in congenital Zika syndrome in infants and the autoimmune Guillain–Barre syndrome in adults warrant the development of safe and efficacious vaccines and therapeutics. Currently, there are no approved treatment options for ZIKV inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Pattnaik, Aryamav, Sahoo, Bikash R., Struble, Lucas R., Borgstahl, Gloria E. O., Zhou, You, Franco, Rodrigo, Barletta, Raul G., Osorio, Fernando A., Petro, Thomas M., Pattnaik, Asit K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143468/
https://www.ncbi.nlm.nih.gov/pubmed/37112733
http://dx.doi.org/10.3390/vaccines11040821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143468/
https://www.ncbi.nlm.nih.gov/pubmed/37112733
http://dx.doi.org/10.3390/vaccines11040821

Ejemplares similares